These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11105067)

  • 1. Predisposition to metabolic acidosis induced by topiramate.
    Montenegro MA; Guerreiro MM; Scotoni AE; Guerreiro CA
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1021-4. PubMed ID: 11105067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate and metabolic acidosis in pediatric epilepsy.
    Takeoka M; Holmes GL; Thiele E; Bourgeois BF; Helmers SL; Duffy FH; Riviello JJ
    Epilepsia; 2001 Mar; 42(3):387-92. PubMed ID: 11442157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate-induced metabolic acidosis: report of two cases.
    Ko CH; Kong CK
    Dev Med Child Neurol; 2001 Oct; 43(10):701-4. PubMed ID: 11665828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topiramate in monotherapy or in combination as a cause of metabolic acidosis in adults with epilepsy].
    Ruiz-Granados VJ; Márquez-Romero JM
    Rev Neurol; 2015 Feb; 60(4):159-63. PubMed ID: 25670045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate and metabolic acidosis: a case series and review of the literature.
    Groeper K; McCann ME
    Paediatr Anaesth; 2005 Feb; 15(2):167-70. PubMed ID: 15675937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate and metabolic acidosis in infants and toddlers.
    Philippi H; Boor R; Reitter B
    Epilepsia; 2002 Jul; 43(7):744-7. PubMed ID: 12102678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy.
    Takeoka M; Riviello JJ; Pfeifer H; Thiele EA
    Epilepsia; 2002 Sep; 43(9):1072-5. PubMed ID: 12199733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic impact of topiramate on acid-base balance and potassium in childhood.
    Belotti EA; Taddeo I; Ragazzi M; Pifferini R; Simonetti GD; Bianchetti MG; Ramelli GP
    Eur J Paediatr Neurol; 2010 Sep; 14(5):445-8. PubMed ID: 20005754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate and metabolic acidosis.
    Wilner A; Raymond K; Pollard R
    Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of topiramate on serum bicarbonate concentrations in adults.
    Garris SS; Oles KS
    Ann Pharmacother; 2005 Mar; 39(3):424-6. PubMed ID: 15701764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperchloremic, normal anion-gap, metabolic acidosis due to topiramate.
    Mathews KD; Stark JE
    Am J Health Syst Pharm; 2008 Aug; 65(15):1430-4. PubMed ID: 18653813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate induced metabolic acidosis and kidney stones - a case study.
    Salek T; Andel I; Kurfurstova I
    Biochem Med (Zagreb); 2017 Jun; 27(2):404-410. PubMed ID: 28694730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy.
    Stowe CD; Bollinger T; James LP; Haley TM; Griebel ML; Farrar HC
    Pharmacotherapy; 2000 Jan; 20(1):105-9. PubMed ID: 10641984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperventilation and cerebrospinal fluid acidosis caused by topiramate.
    Montcriol A; Meaudre E; Kenane N; Asencio Y; Bordes J; Palmier B
    Ann Pharmacother; 2008 Apr; 42(4):584-7. PubMed ID: 18420530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial.
    Tartara A; Sartori I; Manni R; Galimberti CA; Di Fazio M; Perucca E
    Ital J Neurol Sci; 1996 Dec; 17(6):429-32. PubMed ID: 8978450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic acidosis due to topiramate.
    Prescrire Int; 2004 Oct; 13(73):186. PubMed ID: 15499701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate induced metabolic acidosis.
    Ozer Y; Altunkaya H
    Anaesthesia; 2004 Aug; 59(8):830. PubMed ID: 15270982
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and tolerability of topiramate in children.
    Levisohn PM
    J Child Neurol; 2000; 15 Suppl 1():S22-6. PubMed ID: 11218053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.